DB Mark
Impact in
-
- Cardiac Valve Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
-
- Cardiac Imaging and Diagnostics
Papers in
-
- Cardiac, Anesthesia and Surgical Outcomes 5
- Cardiac Valve Diseases and Treatments 2
- Surgery 3
- Coronary Interventions and Diagnostics 3
- Co-authors
- KL Lee (9 shared papers)Harrell Fe (7 shared papers)Pryor Db (8 shared papers)RM Califf (7 shared papers)Muhlbaier Lh (6 shared papers)Rankin Js (4 shared papers)Mark A. Hlatky (7 shared papers)Oldham Hn (4 shared papers)
- Journals
- Circulation (2 papers)Value in Health (1 paper)The Journal of invasive cardiology (1 paper)PubMed (8 papers)
- Partner nations
- United StatesCanada
In The Last Decade
DB Mark
14 papers receiving 372 citations
Peers
Comparison fields: 5 of 43
- Cardiology and Cardiovascular Medicine 205
- Radiology, Nuclear Medicine and Imaging 75
- Surgery 128
- Internal Medicine 4
- Family Practice 2
Countries citing papers authored by DB Mark
This map shows the geographic impact of DB Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DB Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DB Mark more than expected).
Fields of papers citing papers by DB Mark
This network shows the impact of papers produced by DB Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DB Mark. The network helps show where DB Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside DB Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. | 1991 | 122 |
| 2 | Surgical survival benefits for coronary disease patients with left ventricular dysfunction. | 1988 | 105 |
| 3 | Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. | 1992 | 55 |
| 4 | The changing survival benefits of coronary revascularization over time. | 1987 | 44 |
| 5 | Changing efficacy of coronary revascularization. Implications for patient selection. | 1988 | 22 |
| 6 | Rescue Coronary Angioplasty after Failure of Intravenous Streptokinase in Acute Myocardial Infarction: In-Hospital and Long-Term Outcomes | 1989 | 14 |
| 7 | Trends in the Presentation, Management, and Survival of Patients with Coronary Artery Disease: The Duke Database for Cardiovascular Disease | 1988 | 9 |
| 8 | Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. | 2000 | 8 |
| 9 | Percutaneous intervention, surgery, and medical therapy: a perspective from the Duke Databank for Cardiovascular Diseases. | 1994 | 8 |
| 10 | Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy. | 2004 | 3 |
| 11 | Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center. | 1985 | 3 |
| 12 | Long Term Results from the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) Trial: Sustained Benefit of Fibrin-Specific Therapy | 1999 | 1 |
| 13 | Health Economics in the PLATelet Inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns | 2010 | 1 |
| 14 | Clinical Judgment and Therapeutic Decision Making | 1991 | 1 |
| 15 | 2009 | 0 |
About DB Mark
DB Mark is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Clinical Biochemistry and Rheumatology, having authored 15 papers that have together received 396 indexed citations. Recurring topics across this work include Cardiac, Anesthesia and Surgical Outcomes (5 papers), Coronary Interventions and Diagnostics (3 papers), Cardiac Valve Diseases and Treatments (2 papers), Cardiac Imaging and Diagnostics (2 papers), Folate and B Vitamins Research (1 paper), Genomics and Rare Diseases (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (205 citations), Radiology, Nuclear Medicine and Imaging (75 citations), Surgery (128 citations), Internal Medicine (4 citations) and Family Practice (2 citations). DB Mark has collaborated with scholars based in United States and Canada. Frequent co-authors include KL Lee, Harrell Fe, Pryor Db, RM Califf, Muhlbaier Lh, Rankin Js, Mark A. Hlatky, Oldham Hn, Smith Lr and Jones Rh. Their work appears in journals such as Circulation, Value in Health, The Journal of invasive cardiology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.